Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Chronic Obstructive Pulmonary Disease (COPD) in United States

70 results

Sort By:

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Study ID: NCT03500731
Start Date: 2018-04-19
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

8

Intervention / Treatment

CD3/CD19 negative hematopoietic stem cells

Rituximab

Alemtuzumab

Fludarabine

Thiotepa

G-CSF

Hydroxyurea

Sponsor

Paul Szabolcs

Source: clinicaltrials.gov

Share:
Add to list

Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

Study ID: NCT05330507
Start Date: 2022-07-05
End Date: 2024-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Wellinks

Sponsor

Convexity Scientific Inc

Source: clinicaltrials.gov

Share:
Add to list

Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise

Study ID: NCT05896579
Start Date: 2023-08-22
End Date: 2030-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Exercise training

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD

Study ID: NCT05718102
Start Date: 2023-05-15
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

4000

Intervention / Treatment

Population-health management

Sponsor

Seattle Institute for Biomedical and Clinical Research

Source: clinicaltrials.gov

Share:
Add to list

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy

Study ID: NCT03331302
Start Date: 2018-09-01
End Date: 2020-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Hyperpolarized Xenon-129 MRI (Experimental)

Radioactive Xenon-133 scintigraphy (Active Comparator)

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Study ID: NCT05742802
Start Date: 2023-03-06
End Date: 2026-08-17
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1869

Intervention / Treatment

Tozorakimab 1

Tozorakimab 2

Placebo

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

OMEGA - Dietary Intervention - COPD Trial

Study ID: NCT05297279
Start Date: 2022-03-01
End Date: 2027-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Home delivery Omega-3 rich Food

Dietary Motivational Coaching

Home delivery Food

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Biological Effects of Quercetin in COPD Phase II

Study ID: NCT06003270
Start Date: 2023-11-01
End Date: 2025-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Quercetin 1000 mg

Quercetin 500 MG

Placebo

Sponsor

Temple University

Source: clinicaltrials.gov

Share:
Add to list

COPD Patient-Powered Research Network

Study ID: NCT02803242
Start Date: 2014-08
End Date: 2030-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75000

Intervention / Treatment

Patient Reported Outcomes

Sponsor

COPD Foundation

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Study ID: NCT05595642
Start Date: 2022-12-29
End Date: 2027-03-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1290

Intervention / Treatment

Astegolimab

Placebo

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list